| Website | logicaltx.com |
| Category | BioTech |
| Phone | 781-290-0900 |
| Employees | |
| Founded | 2005 |
| TOTAL | $16.9M |
| VENTURE FUNDING TOTAL | $16.9M |
| Series C, 5/10 SV Life Sciences Novo A/S Novitas Capital | $16.9M |
Logical Therapeutics, Inc., a biopharmaceutical company, engages in the development of drugs to treat diseases caused by or associated with excessive inflammation. Its products include LT-NS001, a non-steroidal anti-inflammatory drug for the treatment of chronic inflammatory conditions, such as osteoarthritis; Leptin, a hormone for the regulation of normal body mass and metabolism; and TNF, a hormone that promotes the proliferation of hepatocytes. The company was founded in 2005 and is based in Waltham, Massachusetts.
